‘Tobramycin nebulisation with I-neb (TONI) study in children with cystic fibrosis: pharmacokinetics and safety’.

Recruiting

• Conditions: longinfectie; Cystic fibrosis; taaislijmziekteInhalation antibiotics; inhalatie antibioticaPulmonary infection

• Registration Number: NL-OMON29093
• Lead Sponsor: H.M. Janssens, pulmonologist at Erasmus Medical Center, Rotterdam, The Netherlands

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 24

Inclusion Criteria

•Clinical diagnosis of CF and a positive sweat test or two CF-related mutations;

•Either: early PA infection or colonization with PA requiring eradication with inhaled tobramycin, or: chronic PA colonization requiring maintenance therapy with inhaled tobramycin;

Exclusion Criteria

•Severe acute exacerbation of pulmonary infection (needing intravenous treatment);

Study & Design

• Study Type: Interventional
• Study Design: Not specified